Your browser doesn't support javascript.
loading
Characterization of MHC Class I and ß-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.
Haworth, Kellie B; Arnold, Michael A; Pierson, Christopher R; Leddon, Jennifer L; Kurmashev, Dias K; Swain, Hayley M; Hutzen, Brian J; Roberts, Ryan D; Cripe, Timothy P.
Affiliation
  • Haworth KB; Division of Hematology/Oncology/Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.
  • Arnold MA; Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Pierson CR; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Leddon JL; Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio.
  • Kurmashev DK; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio.
  • Swain HM; Department of Pathology, The Ohio State University College of Medicine, Columbus, Ohio.
  • Hutzen BJ; Division of Anatomy, The Ohio State University, Columbus, Ohio.
  • Roberts RD; Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Cripe TP; Medical Scientist Training Program, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Pediatr Blood Cancer ; 63(4): 618-26, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26575538

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histocompatibility Antigens Class I / Clinical Trials as Topic / Beta 2-Microglobulin / Patient Selection / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2016 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histocompatibility Antigens Class I / Clinical Trials as Topic / Beta 2-Microglobulin / Patient Selection / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Child / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2016 Document type: Article Country of publication: